Faraj B A, Martin L G
Department of Radiology, Emory University School of Medicine, Atlanta, Georgia 30322.
Invest Radiol. 1990 Nov;25(11):1228-31. doi: 10.1097/00004424-199011000-00014.
With the availability of a newly developed, histamine-dependent allergy blood test, the authors studied the effect of ionic and nonionic radiocontrast media (RCM) on the in vitro release of histamine from whole blood obtained from 61 patients undergoing diagnostic arteriography. The ionic RCM, sodium meglumine diatrizoate (60 to 378 mmol/L), induced the release of a significantly (P less than .005) higher amount of histamine from blood compared with the nonionic agents, iopamidol and ioversol. Diatrizoate triggered significantly (P less than .05) more histamine release from the blood of eight patients with a history of adverse reactions to RCM than it did in 53 nonreactors; however, there was no appreciable difference in histamine release between reactive and nonreactive groups when stimulated with iopamidol and ioversol.
随着一种新开发的、依赖组胺的过敏血液检测方法的出现,作者研究了离子型和非离子型放射造影剂(RCM)对61例接受诊断性血管造影患者全血中组胺体外释放的影响。离子型RCM,即葡甲胺泛影酸钠(60至378 mmol/L),与非离子型造影剂碘帕醇和碘佛醇相比,从血液中诱导释放的组胺量显著更高(P小于0.005)。泛影酸盐从8例有RCM不良反应史的患者血液中引发的组胺释放显著(P小于0.05)多于53例无反应者;然而,在用碘帕醇和碘佛醇刺激时,反应组和无反应组之间的组胺释放没有明显差异。